Page last updated: 2024-11-06

ecgonine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ecgonine: RN given refers to (1R-(exo,exo))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ecgonine : A tropane alkaloid that consists of tropane bearing carboxy and hydroxy substituents at positions 2 and 3 respectively and having (1R,2R,3S,5S)-configuration. It is both a metabolite of and a precursor to cocaine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID443003
CHEMBL ID612017
CHEBI ID176716
SCHEMBL ID1649753
MeSH IDM0047264

Synonyms (9)

Synonym
CHEBI:176716
(2r,3s)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
l-ecgonine
ecgonine
481-37-8
CHEMBL612017
SCHEMBL1649753
3-b-hydroxy-2-b-tropanecarboxylic acid
3-beta-hydroxy-2-beta-tropanecarboxylic acid

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The results demonstrated that the plasma elimination half-life of cocaine is nearly three times longer in males versus females."( Gender differences in cocaine pharmacokinetics in CF-1 mice.
Abdel-Rahman, MS; Turkall, R; Visalli, T, 2005
)
0.33

Bioavailability

ExcerptReferenceRelevance
" Bioavailability was good after ni (80%)."( Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.
Cook, CE; Hill, JM; Jeffcoat, AR; Perez-Reyes, M; Sadler, BM,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" The range of the dose-response curve is 0-400 ng ml-1 benzoylecgonine."( Radioimmunoassay of benzoylecgonine in samples of forensic interest.
Robinson, K; Smith, RN, 1984
)
0.27
" Cumulative dose-response curves (10(-12)-10(-4) M) were generated for cocaine and the major cocaine metabolites in fetal sheep cerebral artery segments."( Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries.
Covert, RF; Madden, JA; Schreiber, MD; Torgerson, LJ, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tropane alkaloid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID127476Binding affinity against human monoclonal antibody (mAb) 2E2 relative to cocaine by ELISA method.2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
AID127360Relative binding affinity against human monoclonal antibody 2E2 compared to [3H]cocaine2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
AID127475Relative binding affinity against human monoclonal antibody (mAb) 2E2 compared to cocaine2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (15.00)18.7374
1990's16 (40.00)18.2507
2000's12 (30.00)29.6817
2010's6 (15.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.13%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]